CCG-271423 is a potent and selective GRK5 inhibitor (IC50 = 0.0021 μM for GRK5 vs. 44 μM for GRK2); it inhibits cardiomyocyte contractility and reduces Ca2+ transients; it serves as a click chemistry reagent containing an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.